RxDoctor Payments Data

Michael Blum

Cardiovascular Disease · San Francisco, CANPI 1972568889

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,000 of the $35,000 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Vital Connect, Inc. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,000in general payments, 2019–2025

Across 1 payment — averaging $35,000 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vital Connect, Inc$35K
$5,489,971in research payments, 2019–2025

Across 6 payments — averaging $914,995 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GE HealthCare$5.5M
$5,000in ownership & investment interests, 2019–2025

Across 3 payments — averaging $1666.67 each. An ownership or investment interest held by the physician or an immediate family member.

  • Vital Connect, Inc$5K

What the payments were for

  • Consulting fees$35,000100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vital Connect, Inc1$35,000

How this compares

$35,000 in reported general payments places this provider in the 90th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California

Other cardiovascular disease in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →